![5-Bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one](https://static.cymitquimica.com/products/3D/img/FB42029.png "Click to enlarge")
5-Bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
CAS: 183208-34-6
Ref. 3D-FB42029
| 1g | Discontinued | ||
| 2g | Discontinued | ||
| 5g | Discontinued | ||
| 10g | Discontinued | ||
| 500mg | Discontinued |
Product Information
Name:
5-Bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
Synonyms:
- 5-Bromo-7-Aza-Indolin-2(3h)-One
- 2H-Pyrrolo[2,3-b]pyridin-2-one, 5-bromo-1,3-dihydro-
- 5-bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one
- 5-bromo-1H,2H,3H-pyrrolo[2,3-b]pyridin-2-one
Description:
5-Bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one is a cancer drug that is a potent inhibitor of angiogenesis. This compound has been shown to inhibit tumor growth in vitro and in vivo. 5-Bromo-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one also shows antiangiogenic activity in mouse models of cancer. The antitumor effects of this drug are mediated by inhibition of the protein tyrosine kinases VEGF receptor 1 (VEGFR1) and VEGFR2. Sunitinib is an oral anticancer agent used for the treatment of metastatic renal cell carcinoma and other solid tumors. It has been found to be active against a variety of human cancers including melanomas, lung cancers, breast
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
213.03 g/mol
Formula:
C7H5BrN2O
Purity:
Min. 95%
InChI:
InChI=1S/C7H5BrN2O/c8-5-1-4-2-6(11)10-7(4)9-3-5/h1,3H,2H2,(H,9,10,11)
InChI key:
InChIKey=DHPKTHROZFIEJK-UHFFFAOYSA-N
SMILES:
O=C1Cc2cc(Br)cnc2N1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
